UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000002646
Receipt number R000003222
Scientific Title Effect of Ezetimib on metabolism and renal functions in CKD patients with dysglycemia and high LDL cholesteremia
Date of disclosure of the study information 2009/10/19
Last modified on 2014/08/14 16:49:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of Ezetimib on metabolism and renal functions in CKD patients with dysglycemia and high LDL cholesteremia

Acronym

Effect of Ezetimib on metabolic and renal functions

Scientific Title

Effect of Ezetimib on metabolism and renal functions in CKD patients with dysglycemia and high LDL cholesteremia

Scientific Title:Acronym

Effect of Ezetimib on metabolic and renal functions

Region

Japan


Condition

Condition

CKD patients with dysglycemia and high LDL choresterol

Classification by specialty

Endocrinology and Metabolism Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Effect of Ezetimib on lipids and renal functions

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

1) LDL choresterol
2) Achivement of target LDL choresterol

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Ezetimib

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

CKD with dysglycemia and high LDL choresteremia
1) LDL choresterol higher than 120 mg.dl
2) eGFR higher than 30ml.min.1.73m2

Key exclusion criteria

1) HbA1c higher than 9 percent
2) Allergy to ezetimib
3) Severe hepatic disease
4) pregnancy and suckling
5) familial hyperchoresteremia

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Daisuke Koya

Organization

Kanazawa Medical University

Division name

Endocrinology & Metabolism

Zip code


Address

Daigaku1-1 Uchinadacho Kahokugun Ishikawa

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name Daisuke Koya

Organization

Kanazawa Medical University

Division name

Endocrinology & Metabolism

Zip code


Address

Daigaku1-1 Uchinadacho Kahokugun Ishikawa

TEL


Homepage URL


Email

koya0516@kanazawa-med.ac.jp


Sponsor or person

Institute

Kanazawa Medical University
Endocrinology & Metabolism

Institute

Department

Personal name



Funding Source

Organization

Kanazawa Medical University
Endocrinology & Metabolism

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2009 Year 10 Month 19 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2009 Year 09 Month 18 Day

Date of IRB


Anticipated trial start date

2009 Year 10 Month 01 Day

Last follow-up date

2012 Year 04 Month 01 Day

Date of closure to data entry

2012 Year 06 Month 01 Day

Date trial data considered complete

2012 Year 06 Month 01 Day

Date analysis concluded

2012 Year 06 Month 01 Day


Other

Other related information



Management information

Registered date

2009 Year 10 Month 19 Day

Last modified on

2014 Year 08 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003222


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name